PharmaTher Holdings (XCNQ:PHRM) Days Sales Outstanding : 0.00 (As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Days Sales Outstanding?

PharmaTher Holdings's average Accounts Receivable for the three months ended in Feb. 2024 was C$0.04 Mil. PharmaTher Holdings's Revenue for the three months ended in Feb. 2024 was C$0.00 Mil.

The historical rank and industry rank for PharmaTher Holdings's Days Sales Outstanding or its related term are showing as below:

XCNQ:PHRM's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

PharmaTher Holdings's Days Sales Outstanding stayed the same from Feb. 2023 (0.00) to Feb. 2024 (0.00).

PharmaTher Holdings Days Sales Outstanding Historical Data

The historical data trend for PharmaTher Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Days Sales Outstanding Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Days Sales Outstanding

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Sales Outstanding	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of PharmaTher Holdings's Days Sales Outstanding

For the Biotechnology subindustry, PharmaTher Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Days Sales Outstanding falls into.

PharmaTher Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PharmaTher Holdings's Days Sales Outstanding for the fiscal year that ended in May. 2023 is calculated as

	Days Sales Outstanding (A: May. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: May. 2022 )	+	Accounts Receivable (A: May. 2023 ))	/	count )	/	Revenue (A: May. 2023 )	*	Days in Period
=	( (0.03	+	0.056)	/	2 )	/	0	*	365
=	0.043					/	0	*	365
=	N/A

PharmaTher Holdings's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

	Days Sales Outstanding (Q: Feb. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Nov. 2023 )	+	Accounts Receivable (A: Feb. 2024 ))	/	count )	/	Revenue (A: Feb. 2024 )	*	Days in Period
=	( (0.027	+	0.05)	/	2 )	/	0	*	365 / 4
=	0.0385					/	0	*	365 / 4
=	N/A

PharmaTher Holdings (XCNQ:PHRM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

PharmaTher Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

PHRRF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

Executives

Fabio Chianelli

Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines